|
| Press Releases |
|
 |
|
| Tuesday, April 19, 2022 |
|
|
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organization in APAC |
| Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence. more info >> |
|
| Thursday, March 31, 2022 |
|
|
Avance Clinical Announces New Office Opening in Melbourne |
| Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to support its growing clinical team in the greater Melbourne region. more info >> |
|
| Wednesday, March 2, 2022 |
|
|
Avance Clinical Announces New Office Opening in Sydney |
| Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the greater Sydney region. more info >> |
|
| Tuesday, January 18, 2022 |
|
|
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022 |
| Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m. more info >> |
|
| Tuesday, October 19, 2021 |
|
|
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain |
| Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study evaluating XW10508, the Company's novel, patented, glutamatergic NMDA antagonist and AMPA activator in development as an oral, once-daily therapy for the treatment of treatment-resistant depression and chronic pain. more info >> |
|
| Tuesday, August 10, 2021 |
|
|
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership |
| Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC) CRO Best Practices Award for the company from Frost & Sullivan. more info >> |
|
| Friday, July 9, 2021 |
|
|
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia |
| The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial. more info >> |
|
| Monday, June 28, 2021 |
|
|
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth |
| The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager APAC to support increasing biotech clinical trial demand from the region. more info >> |
|
| Friday, June 4, 2021 |
|
|
Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021. more info >> |
|
| Thursday, May 27, 2021 |
|
|
Avance Clinical Releases Industry Survey Results at BIO Korea 2021 |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data quality to be the most important criteria for selecting a CRO for Phase ll studies in Australia. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
HKTDC Food Expo and concurrent fairs open today 
Aug 11, 2022 21:00 HKT/SGT
|
|
|
Pertamina's rank in Fortune's Global 500 jumps 64 spots
Aug 11, 2022 18:00 HKT/SGT
|
|
|
Habitat for Humanity invests in Cambodian water-access startup TapEffect
Aug 11, 2022 15:37 HKT/SGT
|
|
|
Battle against cyber threats to be addressed by cyber security visionaries at #WCSSJordan
Aug 11, 2022 15:13 HKT/SGT
|
|
|
600+ cybersecurity experts meet at PhilSec 2022 to discuss the future of cybersecurity in the Philippines
Aug 11, 2022 10:36 HKT/SGT
|
|
|
Pacific Green Successfully Executes Its Transition to Renewable Energy Recurring Income Model and Announces Its Annual Report for Year Ending March 31, 2022
Aug 11, 2022 05:00 HKT/SGT
|
|
|
Revolutionary Blockchain-based Dancing Platform, DANSA to Be Launched Soon
Aug 10, 2022 21:00 HKT/SGT
|
|
|
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 21:00 HKT/SGT
|
|
|
CleverTap Raises US$105M in Series D Funding Round Led by CDPQ
Aug 10, 2022 20:50 HKT/SGT
|
|
|
TTI Delivers Strong 2022 First Half Results
Aug 10, 2022 19:25 HKT/SGT
|
|
|
Bintai Kinden to Market O&G Equipment in Indonesia
Aug 10, 2022 13:00 HKT/SGT
|
|
|
Society Pass backed Thoughtful Media Group Announces New CEO and Vision to be the Leader in Digital and Social Commerce in SEA
Aug 10, 2022 12:00 HKT/SGT
|
|
|
India's top BFSI experts Unite to Reshape India's Banking Landscape at #TresconBFSI
Aug 9, 2022 20:42 HKT/SGT
|
|
|
SKYX Achieves Historic U.S. Standardization Approval Vote - a Major Milestone Towards Mandatory Status for Safety of Consumers and Professionals
Aug 9, 2022 20:31 HKT/SGT
|
|
|
Virios Therapeutics: The 'Virus Hypothesis' That Stands to Change the Lives of 10M Americans
Aug 9, 2022 20:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
